Value of Fetal Scalp Lactate Sampling During Labour in Cases of Abnormal Fetal Heart Rate
1 other identifier
observational
100
1 country
1
Brief Summary
ST-analysis of the foetal ECG (STAN®) is another second line technique for intrapartum foetal monitoring. Combining ST-analysis with standard CTG interpretation aims to identify hypoxic foetuses more accurately than CTG alone. The STAN® method identifies changes in the ST-interval of the foetal ECG that occur in the presence of foetalcentral hypoxia The aim of this studie is to investigate if the foetal lactate blood sampling is still useful when STAN® monitoring is already being used as a second line technique for intrapartum foetal monitoring if the fetal heart rate is abnormal without a significant ST event Nowadays in the Montpellier hospital's protocol, the investigators have to check the value of lactate sampling in case of le STAN doesn't detect an ST event. So this studie can change the Montpellier hospital's protocol and avoid useless fetal blood sampling
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Feb 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2022
CompletedFirst Submitted
Initial submission to the registry
February 17, 2022
CompletedFirst Posted
Study publicly available on registry
February 28, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
October 31, 2022
CompletedFebruary 28, 2022
February 1, 2022
3 months
February 17, 2022
February 17, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
the incidence of serious metabolic acidosis
the incidence of serious metabolic acidosis (defined as pH \< 7 and Bdecf \> 12 mmol/L in the umbilical cord artery).
day 1
Secondary Outcomes (2)
Number of the instrumental delivery
day 1
Number of the neonatal outcome
day 1
Eligibility Criteria
women monitored by STAN in active labour with singleton term fetus in cephalic presentation
You may qualify if:
- patient with labor monitoring by ST segment analysis (STAN) according to current guidelines
- patient who received a fetal lactate sample for fetal heart rate classified as pathological for more than 60 minutes
You may not qualify if:
- STAN guidelines not respected before installation and during work
- misclassification of fetal heart rate
- obstetrical complications during labor
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Uhmontpellier
Montpellier, 34295, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
WALTZING Aude
University Hospital, Montpellier
Central Study Contacts
DUPORT-PERCIER Marie, MD
CONTACT
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 17, 2022
First Posted
February 28, 2022
Study Start
February 1, 2022
Primary Completion
May 1, 2022
Study Completion
October 31, 2022
Last Updated
February 28, 2022
Record last verified: 2022-02